Clearance Summary
OXIPROBE E (OXIPROBE) received FDA 510(k) clearance under submission number K132516, sponsored by Bio Medical Technologies Co., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2014-07-30.
- Submission: K132516
- Applicant / Sponsor: Bio Medical Technologies Co., Ltd.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2700
- Decision date: 2014-07-30
Classification & Regulation
This clearance is catalogued under FDA product code DQA and 21 CFR 870.2700, within the Cardiovascular review panel as a Class II device.